Ex Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D<sub>2/3</sub> Receptors

<div>Results of biodistribution studies in Wistar rats. Uptake ratios of uptake in several brain areas compared to cerebellum uptake at different times after intravenous injection of [<sup>123</sup>I]-<b>1</b>.</div>

International Journal of Molecular Imaging

fig1

Figure 1

Figure 1: Ex Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D<sub>2/3</sub> Receptors 

Figure 1 | Ex Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D2/3 Receptors 